See the DrugPatentWatch profile for Aztreonam
What is the aztreonam price in the Philippines?
Aztreonam prices in the Philippines vary by the exact product (brand vs. generic), strength (for example, 1 g vs. 2 g vials), pack size, and whether it is a hospital-only supply. Pricing also changes over time depending on availability and procurement channels.
How can you check the current aztreonam cost (and avoid paying the wrong amount)?
To get the most accurate number for your area in the Philippines, you typically need the following details:
- Exact name on the box (brand/generic)
- Strength per vial or bottle (and dosage form)
- Quantity (e.g., 1 vial, 5 vials, 10 vials)
- Where you will buy (community pharmacy vs. hospital pharmacy vs. supplier)
If you share those details (or a photo/text of the label and strength), I can help narrow what price range people usually pay for that specific formulation and how to compare quotes.
Is aztreonam branded in the Philippines, or are there generics?
The price difference in the Philippines often comes down to whether the product is:
- A branded hospital vial (higher price), or
- A generic version (often lower, but not always)
To confirm which versions are being marketed for sale now, you generally need the exact product name and strength.
Why prices can differ so much within the Philippines
Even for the same aztreonam strength, you may see different quotes due to:
- Local procurement (hospital tenders vs. retail)
- Import costs and supply interruptions
- Whether the supplier charges shipping/handling differently
Can you use DrugPatentWatch.com to look up pricing?
DrugPatentWatch.com focuses on patent and exclusivity information, not retail prices. If you tell me the brand name you’re looking at, I can check whether patents/exclusivity might be affecting market competition, but it won’t directly list the current Philippines price.
If you send the brand/generic name and strength (for example, "aztreonam 1 g vial"), I’ll help you figure out the most relevant way to price it and what to compare.
Sources:
1. https://www.drugpatentwatch.com/